CLONAL ANALYSIS OF COLORECTAL TUMORS USING K-RAS AND P53 GENE-MUTATIONS AS MARKERS

被引:23
作者
DIX, BR
ROBBINS, PD
SPAGNOLO, DV
PADOVAN, GL
HOUSE, AK
IACOPETTA, BJ
机构
[1] UNIV WESTERN AUSTRALIA,DEPT SURG,NEDLANDS,WA 6009,AUSTRALIA
[2] SIR CHARLES GAIRDNER HOSP,DEPT SURG,HOSP & UNIV PATHOL SERV,PERTH,WA,AUSTRALIA
[3] UNIV WESTERN AUSTRALIA,DEPT SURG,PERTH,WA 6009,AUSTRALIA
关键词
CLONAL; K-RAS; COLORECTAL CARCINOMA; MUTATIONS;
D O I
10.1097/00019606-199512000-00006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutations to the K-ras oncogene and p53 tumor suppressor gene are two of the most common genetic lesions in human cancers. In the present study we examined the clonality of colorectal tumors with respect to each of these genetic alterations. Screening for mutations was carried out using the polymerase chain reaction-based technique of single-strand conformation polymorphism. Eleven primary colorectal adenocarcinomas and two secondary adenocarcinomas were analyzed at four different sites within the tumor. Involved pericolic lymph nodes were collected from nine of these cases, a metastatic deposit in the liver was obtained in one case, and adjacent adenomatous lesions were collected in two cases. Seven tumors contained mutations in either the K-las or p53 genes, In all cases, DNA derived from multiple sites within an individual tumor or metastatic deposits arising from that tumor showed the same pattern of gene mutation. Immunohistochemical staining for p53 protein overexpression also showed similar patterns of reactivity within individual tumors and their metastatic deposits. These results suggest that the major clonal expansion of colorectal carcinomas occurs after the acquisition of mutations in these genes. Our results also indicate that sampling errors are unlikely to occur in molecular studies aimed at defining the role of these genes in colorectal cancer progression.
引用
收藏
页码:261 / 265
页数:5
相关论文
共 21 条
[1]  
CARDER P, 1993, ONCOGENE, V8, P1397
[2]   HETEROGENEITY FOR ALLELIC LOSS IN HUMAN BREAST-CANCER [J].
CHEN, LC ;
KURISU, W ;
LJUNG, BM ;
GOLDMAN, ES ;
MOORE, D ;
SMITH, HS .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (07) :506-510
[3]  
CHO JH, 1994, MODERN PATHOL, V7, P205
[4]   COMPARISON OF P53 GENE MUTATION AND PROTEIN OVEREXPRESSION IN COLORECTAL CARCINOMAS [J].
DIX, B ;
ROBBINS, P ;
CARRELLO, S ;
HOUSE, A ;
IACOPETTA, B .
BRITISH JOURNAL OF CANCER, 1994, 70 (04) :585-590
[5]   COMMON MOLECULAR-GENETIC ALTERATIONS IN DUKES-B AND DUKES-C COLORECTAL CARCINOMAS ARE NOT SHORT-TERM PROGNOSTIC INDICATORS OF SURVIVAL [J].
DIX, BR ;
ROBBINS, P ;
SOONG, R ;
JENNER, D ;
HOUSE, AK ;
IACOPETTA, BJ ;
BELL, R ;
CLARKE, G ;
CULLINGFORD, G ;
FAULKNER, K ;
INGRAM, D ;
KERMODE, D ;
KIERATH, A ;
LEVITT, M ;
SMITH, P .
INTERNATIONAL JOURNAL OF CANCER, 1994, 59 (06) :747-751
[6]  
DUGGAN BD, 1994, CANCER RES, V54, P1604
[7]   A GENETIC MODEL FOR COLORECTAL TUMORIGENESIS [J].
FEARON, ER ;
VOGELSTEIN, B .
CELL, 1990, 61 (05) :759-767
[8]  
FEY MF, 1993, CANCER RES, V53, P921
[9]   CLONAL ORIGIN OF HUMAN TUMORS [J].
FIALKOW, PJ .
BIOCHIMICA ET BIOPHYSICA ACTA, 1976, 458 (03) :283-321
[10]   CLONALITY IN MYELOPROLIFERATIVE DISORDERS - ANALYSIS BY MEANS OF THE POLYMERASE CHAIN-REACTION [J].
GILLILAND, DG ;
BLANCHARD, KL ;
LEVY, J ;
PERRIN, S ;
BUNN, HF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (15) :6848-6852